Trafalgar International (GCAN) Cash from Investing Activities (2020)
Trafalgar International (GCAN) posted Cash from Investing Activities of -$36750.0 for Q4 2020, down 47.0% on a QoQ basis from -$25000.0 in Q1 2020.
Powered by 
Analysis
Trafalgar International (GCAN) Cash from Investing Activities (2020) Analysis & Trends
Trafalgar International has reported Cash from Investing Activities for 1 years, with the latest figure at -$36750.0 in Q4 2020.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$36750.0 in Q4 2020; TTM through Dec 2020 was -$61750.0, a N/A change from a year earlier, with the FY2020 full-year figure at -$61750.0, changed N/A from the prior year.
- Cash from Investing Activities was -$36750.0 for Q4 2020 at Trafalgar International, down from -$25000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$25000.0 in Q1 2020, with the low at -$36750.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -1.11 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -1.20 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -5.60 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -3.11 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 2.11 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -424.26 Mn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | -1.66 Bn |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -51.79 Mn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 87.50 Mn |
| 10 | Trafalgar International | 217,335.05 | 217,335.05 | - | - |